A combined antitumor strategy of separately transduced mesenchymal stem cells with soluble TRAIL and IFNβ produces a synergistic activity in the reduction of lymphoma and mice survival enlargement

As the understanding of cancer grows, new therapies have been proposed to improve the well-known limitations of current therapies, whose efficiency relies mostly on early detection, surgery and chemotherapy. Mesenchymal stem cells (MSCs) have been introduced as a promissory and effective therapy. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Quiroz-Reyes, Adriana G., González-Villarreal, Carlos A., Martínez-Rodriguez, Herminia, Said-Fernández, Salvador, Salinas-Carmona, Mario César, Limón-Flores, Alberto Y., Soto-Domínguez, Adolfo, Padilla-Rivas, Gerardo, Montes De Oca-Luna, Roberto, Islas, Jose F., Garza-Treviño, Elsa N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073847/
https://www.ncbi.nlm.nih.gov/pubmed/35485288
http://dx.doi.org/10.3892/mmr.2022.12722

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073847/
https://www.ncbi.nlm.nih.gov/pubmed/35485288
http://dx.doi.org/10.3892/mmr.2022.12722

Ejemplares similares